Canaccord Genuity Starts Cerulean Pharma (CERU) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Leerink Swann Starts Cerulean Pharma (CERU) at Outperform
May 6, 2014 9:11 AM EDTLeerink Swann initiated coverage on Cerulean Pharma (NASDAQ: CERU) with an Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
... MoreWedbush Starts Cerulean Pharma (CERU) at Outperform
May 6, 2014 7:33 AM EDTWedbush initiated coverage on Cerulean Pharma (NASDAQ: CERU) with an Outperform rating and a price target of $12.00.
Analyst David M. Nierengarten said, "CERUs nanopharmaceutical technology takes advantage of the local tumor environment to preferentially target, accumulate and release chemotherapy directly to the tumor cells. This capability has changed camptothecin from a drug... More
JMP Securities Starts Cerulean Pharma (CERU) at Market Outperform
May 6, 2014 6:38 AM EDTJMP Securities initiated coverage on Cerulean Pharma (NASDAQ: CERU) with a Market Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $6.75 yesterday.
... More